Presented today at the ESMO Congress 2023, results of the phase III LITESPARK-005 study show that treatment with belzutifan versus…
Renal cell carcinoma
Published in The New England Journal of Medicine (1) results of the phase 3 COSMIC-313 trial show that the addition…
